Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors clinical trial (NCT04974957). Contact the study team or your healthcare provider for specific answers.

What this study is about